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ABSTRACT 
Objective: The present study was planned to explore the antimutagenic response of ethanolic extracts of pollen grains of four plant species viz., 
Bauhinia variegata, Cassia biflora, Cassia glauca and Cassia siamea belonging to Fabaceae family. 
Methods: Ames assay was used to evaluate the antimuatagenic activity of the ethanolic extracts of pollen grains of four plant species. Both TA 98 
and TA 100 strains of Salmonella typhimurium were used in presence and absence of S9 mix during the present study. 
Results: Among four species studied, pollen extracts of Bauhinia variegata and Cassia biflora had shown maximum percentage inhibition of 
revertant colonies during presence and absence of S9 mix, respectively. 
Conclusion: The present study reveals that pollen extract of four plant species viz., Bauhinia variegata, Cassia glauca, Cassia biflora and Cassia 
siamea exhibited antimutagenic potential against two direct acting mutagens viz., (4 nitro-o-phenylenediamine; NPD for TA 98 and sodium azide for 
TA 100) and one indirect acting mutagen (2 amino-flourine; 2AF) which indicates that pollen grains of these species can act as potential source of 
anticancer drugs. 
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INTRODUCTION  
Various damages to the genetic materials such as gene mutations, 
changes in number and structure of chromosomes can ultimately 
lead to cancer [1]. Damages to the genetic material are caused by 
different mutagens or carcinogens. Most of these mutagens are 
present in the environment itself which include chemical 
carcinogens and radiations. However, some other carcinogens enter 
the environment either by natural causes or anthropogenic activities 
[2-3]. These mutagens cause oxidative stress which leads to 
formation of reactive oxygen species such as superoxide anion 
radicals, hydroxyl radicals, hydrogen peroxide in human body [4]. 
Due to oxidative stress, human body releases more reactive oxygen 
species that result in homeostatic imbalance in the body and can 
cause cell damage [4-5]. 
Nowadays, exposure to these mutagens by human body is unavoidable. 
However, intake of antioxidants from medicinal plants can reduce the 
risk of these diseases. Some scientists are looking for natural foodstuffs 
which have antioxidant properties. Considering this, tremendous work 
has now been carried out all over the world to explore the antioxidant 
and antimutagenic potential of medicinal plants [6-8]. 
It is widely accepted that antioxidants present in medicinal plants 
play an important role in reduction of oxidative stress. The 
medicinal plants possess various secondary metabolites such as 
flavonoids, phenolics and terpenoids compounds which may reduce 
or inhibit the mutagenic potential of mutagens. Therefore, it 
becomes important to explore more plants/plant parts possessing 
antimutagenic properties [6-9]. The antimutagenic potential of 
various plant species have been explored using number of bioassays 
[10-11]. Among different bioassays, Ames assay is widely used and 
accepted bioassay to explore the antimutagenic potential of various 
plant species [6-7, 12]. 
The present study focuses on the antimutagenic potential of pollen 
grains of four species viz., Bauhinia variegata, Cassia biflora, Cassia 
glauca and Cassia siamea belonging to fabaceae family. Traditionally, 
Bauhinia variegata has been used to cure number of diseases such as 
piles, diarrhoea, dysentery, oedema, constipation, antidote for snake 
bite, haemorrhoids [13]. Nowadays, different parts of Bauhinia 
variegata also been explored for antibacterial [14], anti-
inflammatory, antimutagenicity [15]. C. biflora has been reported to 
have different phytochemicals such as flavonoids, phenols, proteins, 
sapnonins, terpenoids etc. [16]. Gupta et al., [17] reported that 
leaves of C. glauca showed presence of different phytochemicals viz., 
glycosides, carbohydrates, phenolic compounds, tannins, alkaloids 
etc. Majji et al., [18] reported the antibacterial activity of C. siamea. 
The pollen grains of various plant species have been reported to 
possess various bioactive compounds such as flavonoids, terpenoid, 
and polyphenols [19-22]. These bioactive compounds have been 
well documented for their different bioactivities such as antifungal, 
antibacterial, antioxidant, antimutagenicity, anti-inflammatory [19]. 
Considering this, the present study was planned to explore the 
antimutagenic potential of pollen grains of four plant species viz., 
Bauhinia variegata, Cassia biflora, Cassia glauca and Cassia siamea.  
MATERIALS AND METHODS 
Chemicals and reagents used  
Different chemicals used in the study i.e. disodium hydrogen 
orthophosphate (Na2HPO4.2H2O), potassium dihydrogen 
orthophosphate (KH2PO4.2H2O), ammonium chloride (NH4Cl), 
sodium chloride (NaCl), magnesium sulphate (MgSO4), calcium 
chlorides (CaCl2), glucose, histidine, biotin, agar, nicotine adenine 
dinucleotide phosphate, glucose-6-phosphate, MgCl2
Collection of pollen grains  
 and KCl 
procured from Himedia Company. Two direct acting mutagens viz., 
(4 nitro-o-phenylenediamine; NPD for TA 98 and sodium azide for 
TA 100) and one indirect acting mutagen (2 amino-flourine; 2AF for 
both strains) were used in the experiment. 
Four medicinal plants viz., Bauhinia variegata, Cassia glauca, Cassia 
biflora and Cassia siamea belonging to Fabaceae family were selected 
for the present study in order to explore the antimutagenic potential 
of their pollen grains. Botanical identification of different plant 
species were made by studying the morphological features of plants 
and by comparing with the herbarium sheet of the plants which 
were earlier submitted to the herbarium of Department of Botanical 
and Environmental Sciences, GNDU, Amritsar [23].  
Fresh flowers (just prior to anthesis) of plant species were collected 
from the Guru Nanak Dev University Campus, Amritsar, Punjab 
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(India). For collection of pollen grains, anthers were teased with the 
help of sharp forceps and were tapped in pre weighted Petri plates. 
The weight of Petri plates with pollen was noted again. About 100-
150 flowers of each plant were collected in order to obtain 1 g of 
pollen grains.  
Preparation of pollen extracts 
The ethanolic pollen extracts of all plant species were prepared by 
following the protocol given by Carpes et al. [19] with certain 
modifications. 70 % ethanol (7.5 ml) was added to the collected 
pollen grains and then extracted by 1 min shaking at interval of 10 
min at 70 °C temperature for 1 h. After 1 h, the supernatant was 
extracted from the mixture and solid residue was re-dissolved in 
same volume of ethanol. The extraction was repeated till the extracts 
became colourless. The extracts were stored at 4 ºC till further 
analysis. 
Estimation of antimutagenic potential of pollen extracts 
Antimutagenicity of pollen extracts was estimated using Ames assay. 
The Ames test was performed by following the method of Moran and 
Ames [12] using two tester strains of Salmonella typhimurium i.e. 
TA98 and TA100. The test was carried out in the presence of S9 mix 
rat liver homogenate (with metabolic activation) and in absence of 
S9 mix rat liver homogenate (without metabolic activation).  
To know the antimutagenic potential of pollen extracts against direct 
acting mutagens (4 nitro-o-phenylenediamine (NPD) for TA 98 and 
sodium azide (SA) for TA 100), 2 ml of top agar, 0.1 ml of culture (TA 
98 or TA 100), 0.1 ml pollen extract, 0.1 ml mutagen (20 µg/0.1 
ml/plate of 4 nitro-o-phenylenediamine for TA 98 and 2.5 µg/0.1 
ml/plate sodium azide for TA 100) were added to the test mixture. 
To know the antimutagenic potential of pollen extracts against 
indirect acting mutagen (2 amino-flourine; 2AF) by metabolic 
activation of pollen extracts, 2 ml of top agar, 0.1 ml of culture (TA 
98 or TA 100), 0.1 ml pollen extract, 0.5 ml of S9 rat liver 
homogenate and 2 amino-flourine (2AF; 20 µg/0.1 ml/plate) were 
added in test mixture. The mixture was spread on minimal agar 
plates. After solidification, the Petri plates were kept in the BOD 
incubator at 37 °C for 48 h. The number of revertant colonies was 
counted after 48 h.  
For checking antimutagenecity, two modes of treatments viz., pre-
incubation (PI) and co-incubation (CI) were followed. During pre-
incubation, mutagen and pollen extract were pre-incubated at 37 °C 
for 30 min prior to their use while for co-incubation, mutagen and 
extract were mixed at the time of experiment.  
Preparation of S9 
After taking permission from ethical committee (vide no. 226/ 
CPCSEA2013/17 dated 24/08/2013), 5 rats (body weight: 120-150 
gm approximately) were procured from Sanjay Biologicals, Amritsar. 
Rats were kept in animal house of Guru Nanak Dev University for 10 d 
for acclimatization. After acclimatization, rats were treated with 0.1% 
phenobarbitone for 7 d and then livers were excised from the rats. 
Freshly excised livers from the rats were immediately placed in pre-
weighed beakers. Livers were washed several times with the help of 
fresh chilled KCl and weights of livers were noted. The washed livers 
were transferred to sterile beakers containing chilled sterile 0.15 M 
KCl (3 ml/g wet liver). Livers were cut into small pieces with 
scissors and homogenized. The homogenate was then centrifuged at 
9,000 x g (8,700 rpm) for 10 min. The supernatant (S9 fraction) was 
separated from pallets and distributed in 2 ml cryovials. The 
cryovials were immediately transferred to-80ºC till further use. For 
preparation of S9 mix, 16.75 ml of sterile distilled water was added 
in autoclaved culture tube. 25 ml of 0.2 M phosphate buffer (pH 7.4), 
2 ml of 0.1 M nicotine adenine dinucleotide phosphate (NADP), 0. 25 
ml of 1 M glucose-6-phosphate (G-6-P), 1 ml of MgCl2
Statistical analysis 
-KCl salt 
solution and 5 ml of S9 rat liver homogenate were added to it. All the 
solutions were always added in the order indicated above and S9 
mix was maintained at 4 °C during the whole experiments.  
The results were analyzed statistically using one way and two way 
analysis of variance (ANOVA). 
RESULTS AND DISCUSSION  
Antimutagenic response of pollen extracts with and without 
metabolic activation is shown in tables 1-4. Pollen extracts of all 
plant species exhibited dose dependent response.  
 
Table 1: Antimutagenic potential of pollen extracts of Bauhinia variegata 
Treatment  Dose TA 98 TA 100 

























Spontaneous  - 24.0±2.082 - 21.67±1.453 - 93.67±6.566 - 112.0±7.767 - 
Positive control (µg/0.1 ml) 
NPD 20 1147±22.19 - - - - - - - 
Sodium azide 2.5 - - - - 1693±27.06 - - - 
2AF 20 - - 1288±12.22 - - - 1898±5.239 - 
Negative Control 
 25% 27.67±0.333 - 25.67±1.453  - 86.67±2.028  - 105.7±5.364  - 
 50% 23.00±2.517  - 24.00±1.155  - 90.33±5.487  - 118.0±4.163  - 
 75% 25.33±0.882  - 22.67±1.764  - 85.67±4.177  - 110.3±5.812  - 
 100% 29.00±2.309  - 26.67±1.453  - 89.00±5.132  - 114.0±2.887  - 
Co-incubation 
 25% 710.7±22.19 37.07±2.044 754.7±18.67 42.25±1.429 1128±16.380 36.60±0.999 1138±36.68 42.27±2.225 
 50% 630.7±7.424  44.25±0.639 669.3±19.68  48.94±1.531 884.0±40.460  50.50±2.697 992.0±26.63  50.88±1.616 
 75% 575.3±16.9 49.43±1.535 496.0±34.70 62.60±2.822 829.3±11.620 53.59±0.720 764.7±35.88  63.38±2.096 
 100% 437.0±26.26 62.32±2.336 257.3±28.20 81.71±2.180 777.3±57.010 57.07±3.459 532.0±49.65 76.55±2.694 
F-ratio  34.7774*  70.4876*  21.167*  48.5235*  
HSD  88.3962  118.446  164.7492  172.603  
Pre-incubation 
 25% 766.7±14.11 31.91±1.308 888.3±28.42 32.19±1.904 1165±16.38  32.85±1.061 1274±32.15 34.77±1.738 
 50% 669.3±5.812 40.71±0.617 698.7±27.55 46.70±2.179 1049±55.83 40.17±3.552 985.3±39.82 50.75±2.607 
 75% 482.7±19.37  57.95±1.775 505.3±13.68 61.85±1.019 957.3±81.37  48.98±3.588 811.3±42.15 60.75±2.164 
 100% 329.3±16.38 71.19±0.903 300.7±41.25 78.27±3.246 928.0±34.87 47.71±2.305 534.7±55.10 76.41±3.120 
F-ratio  173.1792*  73.8626*  4.072402  51.75473*  
HSD  67.0548  133.1436  239.9333  195.2635  
Two way ANOVA:  
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Co-incubation and Pre-incubation 
 TA 98 (without S9) TA 98 (With S9) TA 100 (without S9) TA 98 (With S9) 
Treatment F-ratio (1,16) F-ratio  = 0.4629 (1,16) F-ratio  = 7.5139* (1,16) F-ratio  = 12.5930* (1,16) = 2.4111 
Dose F-ratio (3,16) F-ratio  = 123.0168* (3,16) F-ratio  = 142.7909* (3,16) F-ratio  = 17.9221* (3,16)
Treatment × Dose 
 = 99.3912* 
F-ratio (3,16) F-ratio  = 13.6037* (3,16) F-ratio  = 1.9523 (3,16) F-ratio  = 1.1772 (3,16)
 
 = 1.2835 
    
* represents the significance at p ≤ 0.05, n=3. 
Table 2: Antimutagenic potential of pollen extracts of Cassia biflora 
Treatment  Dose TA 98 TA 100 

























Spontaneous  - 22.0±1.528 - 22.33±0.882 - 87.67±3.383 - 111.0±6.936 - 
Positive control (µg/0.1 ml) 
NPD 20 1180±18.33 - - - - - - - 
Sodium azide 2.5 - - - - 1696±13.18 - - - 
2AF 20 - - 1295±6.96 - - - 1914±8.452 - 
Negative Control 
 25% 23.00±2.082 - 24.67±2.028  - 93.0±2.517  - 100.3±7.535  - 
 50% 23.67±0.667  - 21.33±1.453  - 94.0±4.509  - 102.0±6.083  - 
 75% 22.67±1.202  - 24.33±1.202  - 83.67±2.728  - 104.0±6.557  - 
 100% 26.33±2.186  - 23.0±1.155  - 82.33±8.452  - 103.3±4.485  - 
Co-incubation 
 25% 766.7±12.72 35.72±1.06 1111.0±35.14  14.38±2.743 865.3±20.18  51.73±1.272 1662.0±6.119 13.83±0.357 
 50% 78.0±27.01  43.41±2.322 932.0±30.02  28.44±2.420 33.3±32.36  60.02±2.054 455.0±19.54  25.28±1.161 
 75% 572.0±24.98  52.53±2.106 850.3±23.38  34.84±1.919 558.7±21.83  70.48±1.348 1396.0±6.110 28.58±0.404 
 100% 508.0±17.44  58.24±1.416 657.3±34.05 50.09±2.647 310.7±7.424 86.18±0.225 1233.0±4.807  37.60±0.322 
F-ratio  28.7498*  36.935*  115.7872*  262.8037*  
HSD  96.6046  140.3996  100.9331  49.6064  
Pre-incubation 
 25% 722.7±23.13  39.52±1.931 1132.0±14.33 12.79±1.108 920.0±34.64 48.31±2.097  1462.0±28.21  24.94±1.420 
 50% 661.3±19.64  44.85±1.676 1074.0±7.211  17.29±0.569 738.7±35.88  59.67±2.122 1153.0±57.62  38.29±3.281 
 75% 518.7±24.69  57.14±2.148 862.7±26.34 33.98±2.105 582.7±39.75  68.98±2.357 1049.0±27.55  46.64±1.186 
 100% 345.3±19.91  72.35±1.739 674.0±26.03 48.78±2.007  454.7±19.64  77.21±1.29 1010.0±36.80 49.89±1.913 
F-ratio  58.4661*  107.5395*  36.27146*  26.9008*  
HSD  99.4309  91.4049  151.1509  178.1464  
Two way ANOVA:  
 
Co-incubation and Pre-incubation 
 TA 98 (without S9) TA 98 (With S9) TA 100 (without S9) TA 98 (With S9) 
Treatment F-ratio (1,16) F-ratio  = 20.4324* (1,16) F-ratio  = 6.6914* (1,16) F-ratio  = 8.0731* (1,16) = 172.6150* 
Dose F-ratio (3,16) F-ratio  = 83.6655* (3,16) F-ratio  = 113.0162* (3,16) F-ratio  = 119.2404* (3,16)
Treatment × Dose 
 = 84.9863* 
F-ratio (3,16) F-ratio  = 4.4071* (3,16) F-ratio  = 2.8892 (3,16) F-ratio  = 2.3466 (3,16)
 
 = 2.7663 
    
* represents the significance at p ≤ 0.05, n=3 
 
Table 3: Antimutagenic potential of pollen extracts of Cassia glauca 
Treatment  Dose TA 98 TA 100 

























Spontaneous  - 23.33±0.882 - 23.67±1.202 - 87.67±3.383 - 112.7±5.457 - 
Positive control (µg/0.1 ml) 
NPD 20 1090.0±98.03 - - - - - - - 
Sodium azide 2.5 - - - - 1696.0±13.86 - - - 
2AF 20 - - 1200.0±8.327 - - - 1891±41.38 - 
Negative Control 
 25% 26.33±4.631 - 23.33±0.882 - 92.33±5.783 - 100.3±7.688 - 
 50% 19.67±0.882 - 25.33±2.603 - 94.67±6.009 - 100.3±5.239 - 
 75% 27.33±1.202 - 25.67±1.453 - 83.67±4.256 - 111.3±4.910 - 
 100% 30.67±4.055 - 27.00±1.155 - 91.00±5.774 - 95.33±1.667 - 
Co-incubation 
 25% 786.7±10.41 28.51±0.852 617.7±10.71 46.86±0.588  949.3±42.85 46.58±2.823 1252±25.56 34.59±0.562  
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 50% 730.0±3.606 33.63±0.364 536.3±10.2 56.50±0.980  781.3±36.54 56.88±2.237 1010±35.10 49.21±1.834 
 75% 686.0±6.557 38.13±0.642 475.7±4.63 61.68±0.471  702.7±23.13 61.61±1.459 835.0±55.77 59.35±3.292  
 100% 589.0±8.743 47.28±0.655 371.0±5.13 70.43±0422 525.3±17.64 72.85±0.962 550.0±35.00 74.68±1.878  
F-ratio  115.3407*  161.9928*  30.8641*  56.1271*  
HSD  35.1541  36.9873  143.5692  178.6513  
Pre-incubation 
 25% 761.3±4.807 30.85±0.399 740.7±7.688 39.04±0.677  1081±19.37 38.34±1.339 1322±12.39 31.79±0.606  
 50% 686.7±8.110 37.68±0.735 641.7±16.70 47.53±1.347  792.0±16.65 56.45±1.063 1104±22.06 43.97±1.239  
 75% 469.3±16.38 58.60±1.651 517.3±2.728 58.08±0.314  673.0±40.55 63.44±2.654 1032±15.30 48.25±0.848  
 100% 370.3±15.72 67.90±1.426 433.0±11.36 65.39±0.946  472.0±17.44 76.26±1.010 919.0±11.85 54.13±0.617  
F-ratio  220.7451*  154.9193*  99.77125*  113.4734*  
HSD  55.6860  49.3298  115.5125  72.1489  
Two way ANOVA:  
 
Co-incubation and Pre-incubation 
 TA 98 (without S9) TA 98 (With S9) TA 100 (without S9) TA 98 (With S9) 
Treatment F-ratio (1,16) F-ratio  = 300.4921* (1,16) F-ratio  = 148.7503* (1,16) F-ratio  = 0.5439 (1,16) = 73.7140* 
Dose F-ratio (3,16) F-ratio  = 328.1444* (3,16) F-ratio  = 307.2856* (3,16) F-ratio  = 111.7861* (3,16)
Treatment × Dose 
 = 118.1121* 
F-ratio (3,16) F-ratio  = 53.2730* (3,16) F-ratio  = 7.6441* (3,16) F-ratio  = 4.0980* (3,16)
 
 = 10.2250* 
    
* represents the significance at p ≤ 0.05 
 
Table 4: Antimutagenic potential of pollen extracts of Cassia siamea 
Treatment  Dose TA 98 TA 100 

























Spontaneous  - 23.33±0.882 - 23.67±1.202 - 92.00±2.517 - 119.0±3.512 - 
Positive control (µg/0.1 ml) 
NPD 20 1096.0±64.69 - - - - - - - 
Sodium azide 2.5 - - - - 1693.0±23.7 - - - 
2AF 20 - - 1325.0±15.07 - - - 1803±10.73 - 
Negative Control 
 25% 20.67±1.453 - 22.33±1.764 - 94.67±5.487 - 110.3±2.963 - 
 50% 26.00±2.00 - 23.33±1.453 - 91.67±3.844 - 109.3±6.741 - 
 75% 24.67±0.882 - 23.00±2.082 - 89.33±4.667 - 101.7±10.27 - 
 100% 24.67±2.186 - 22.33±1.764 - 82.00±3.215 - 105.7±8.172 - 
Co-incubation 
 25% 722.7±21.46 36.67±1.979 869.3±12.72 34.98±0.947 952.0±18.90 46.36±1.151 1233±13.97 33.70±0878  
 50% 665.0±9.018 42.07±0.855 833.3±4.807 37.77±0.357 868.0±25.72 51.52±1.604 1097±22.78 41.71±1.501 
 75% 564.0±11.79 51.16±1.108 809.3±8.819 39.60±0.615 669.3±7.424 62.82±1.614 907.3±8.667 52.68±0.765 
 100% 514.7±6.36 55.63±0.685 617.7±5.548 54.30±0.357 553.3±13.13 70.74±0.882 758.7±7.424 61.55±0329 
F-ratio  49.4528*  172.7259*  106.4099*  206.4384*  
HSD  60.8278  38.7999  79.9587  65.8193  
Pre-incubation 
 25% 536.0±11.55 51.70±1.018 757.3±3.528 43.55±0.269 984.0±29.48 44.36±1.899 1105±10.69 41.27±0.571 
 50% 464.0±12.86 60.29±1.252 703.0±5.196 47.79±0.433 781.3±22.19 57.56±1.411 1052±9.238 44.18±0.604 
 75% 409.3±12.72 65.17±1.168 679.0±6.245 49.61±0.411 664.0±28.84 64.17±1.788 942.7±31.52 50.62±2.163 
 100% 305.3±16.38 74.59±1.530 473.0±36.86 65.05±3.147 581.3±29.69 69.33±1.945 801.7±5.044 59.02±0.576 
F-ratio  51.8666*  43.1163*  39.6909*  58.9809*  
HSD  61.1503  85.8544  125.6117  79.0770  
Two way ANOVA:  
 
Co-incubation and Pre-incubation 
 TA 98 (without S9) TA 98 (With S9) TA 100 (without S9) TA 98 (With S9) 
Treatment F-ratio (1,16) F-ratio  = 389.6272* (1,16) F-ratio  = 154.6817* (1,16) F-ratio  = 0.2369 (1,16) = 4.4047 
Dose F-ratio (3,16) F-ratio  = 99.7351* (3,16) F-ratio  = 129.7817* (3,16) F-ratio  = 115.0549* (3,16)
Treatment × Dose 
 = 226.1555* 
F-ratio (3,16) F-ratio  = 1.5970 (3,16) F-ratio  = 0.41424 (3,16) F-ratio  = 2.8048 (3,16)
 
 = 12.5039* 
    
* represents the significance at p ≤ 0.05, n=3addition of S9 mix, the inhibitory effect of pollen extracts of Bauhinia variegata and Cassia glauca were 
increased.  
 
Among all sample studied, maximum percentage inhibition of 
revertant colonies against 2amino-fluorine were shown by pollen 
extracts of Bauhinia variegata. During co-incubation treatment of TA 
100, maximum percentage inhibition (86.18 %) of revertant colonies 
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was showed by pollen extract of Cassia biflora while minimum 
percentage inhibition (52.93 %) of revertant colonies was showed by 
pollen extract of Bauhinia variegata against sodium azide. The pollen 
extract of Bauhinia variegata showed maximum percentage inhibition 
(81.70 %) of revertants colonies while pollen extracts of Cassia siamea 
showed minimum percentage inhibition (50.09 %) of revertants 
colonies against NPD during co-incubation of TA 98. During pre-
incubation, maximum and minimum percentage inhibitory effect 
against NPD was shown by Bauhinia variegata (78.27 %) and Cassia 
biflora (48.78 %), respectively. The pollen extract of Cassia biflora 
plant showed less inhibitory effects against mutagen NPD and SA in 
both TA 98 and TA 100 cultures. It was observed that with the 
Ames test is widely used test because it is considered as most quick and 
convenient method to test antimutagenicity of any test compounds [7]. It 
is well documented that various types of bioactive compounds are 
present in the different parts of plants and showed their bioactivities 
[4,7,11,24]. Pedeschi and Cisneros-Zevallos [25] reported the 
antiutagenic response of phenolic fraction extracted from Zea mays L. 
Mimica-Dukic et al. [26] reported the antimutagenecity of essential oil 
from leaves of Myrus communis L. and screened for its antimutagenic 
response following Ames assay. Author reported that the antimutagenic 
response of plant is due to presence of 1,8-cineole and methyl eugenol 
compounds because these compounds are responsible for the 
scavenging activity of the oil. Author further stated that phenolic 
compounds present in the methanolic and ethanolic extracts of leaves of 
this plant also responsible for antimutagenic potential. Sundaram et al. 
[27] reported the antimutagenicity of ethanolic extracts of Derris 
brevipes against different mutagens viz., 4-nitroquinolene-1-oxide, 
sodium azide and 2-aminoflourene. The plant was previously used for 
enhancing the brain memory and concentration. Zahin et al. [4] analyzed 
leaves of Murraya koengii L. for their antimutagenic response. In spite of 
presence of bioactive compounds in other parts of the plants, the pollen 
grains of various plants also possess these compounds which further 
contribute to different bioactivities including anti-mutagenic potential of 
pollen grains [4, 19]. 
The literature survey indicated that although many reports are 
available on the use of various plant parts viz., leaves, bark, flowers 
of these plants to explore their bioactivities but no report is 
available on the use of their pollen grains. Therefore, the present 
study is a nobel work to explore the antimutagenic response of the 
pollen grains of four plant species viz., Bauhinia variegata, Cassia 
biflora, Cassia glauca, and Cassia siamea. 
CONCLUSION  
The present study reveals that pollen extract of four plant species 
viz., Bauhinia variegata, Cassia glauca, Cassia biflora and Cassia 
siamea exhibited antimutagenic potential against two direct acting 
mutagens viz., (4 nitro-o-phenylenediamine; NPD for TA 98 and 
sodium azide for TA 100) and one indirect acting mutagen (2 amino-
flourine; 2AF) which indicates that pollen grains of these species can 
act as potential source of anticancer drugs. 
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